Streetbeat News

Earnings

ACN

Accenture's stock is trading lower due to mixed financial results for the second quarter.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:49 am

AMAT

AMD

AVGO

INTC

KLAC

LRCX

MU

NVDA

ON

TSM

Semiconductor stocks are trading higher following Micron's announcement of better-than-expected Q2 financial results and strong Q3 guidance. This positive news from Micron has had a sympathetic impact on the broader semiconductor sector.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:48 am

DBI

Designer Brands (NYSE:DBI) reported Q4 adjusted losses of $(0.44) per share, beating estimates of $(0.47), and sales of $754.35M, surpassing estimates of $747.35M. This represents a 728.57% decrease in earnings and a 0.81% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:48 am

TITN

Titan Machinery (NASDAQ:TITN) reported Q4 sales of $852.13M, surpassing the $724.20M estimate by 17.67% and marking a 46.17% increase from the previous year's $582.98M.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:46 am

CMC

Commercial Metals (NYSE:CMC) reported Q2 adjusted EPS of $0.88, surpassing the $0.73 estimate, with sales of $1.85B also beating the $1.80B estimate. However, this represents a 38.89% decrease in EPS and an 8.42% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:46 am

MU

Micron Technology's shares surged following the announcement of their Q2 financial results, which exceeded expectations, and the company's issuance of strong Q3 guidance.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:46 am

RMTI

Rockwell Medical's shares surged following the announcement of its Q4 FY2023 earnings and the release of its FY2024 guidance.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:45 am

EYEN

NN

OVID

Insiders at NextNav, Eyenovia, and Ovid Therapeutics have made significant purchases of their companies' stocks, indicating potential confidence in their future prospects. NextNav and Eyenovia reported worse-than-expected financial results, while Ovid Therapeutics posted upbeat quarterly sales.

Portfolio Pulse from Avi Kapoor

March 21, 2024 | 10:45 am

ACN

Accenture (NYSE:ACN) reported Q2 adjusted EPS of $2.77, surpassing the $2.66 estimate, marking a 4.14% beat and a 2.97% increase from last year's $2.69. However, its sales of $15.80B slightly missed the $15.84B estimate by 0.26%, representing a minor 0.09% decrease from the previous year's $15.81B.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:42 am

YRD

Yiren Digital reported a Q4 EPS of $0.91, up 16.54% from $0.78 YoY, with sales reaching $179.48M, a 13.77% increase from $157.76M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:36 am